NuSirt Biopharma, Inc. has developed a breakthrough technology platform that combines natural compounds with various pharmaceutical agents.

The company has protected the discovery and application of this broad based technology platform through an extensive IP portfolio that includes two issued patents and thirteen active patent applications. NuSirt has successfully conducted multiple clinical studies that have validated its discovery and demonstrated the value of its intellectual property.

Learn More

Call 877-821-8713

Or Request more information.

NuSirt News

Phase 2A study initiated, centers screening Type 2 diabetes patients in 8 US centers


See All News


1600 Division Street, Suite 580
Nashville, TN 37203